With Limited COVID-19 Vaccine Doses, Who Would Get Them First?
A CDC advisory committee is debating this issue Tuesday. Half of U.S. adults could be considered high priority yet the initial supply is likely to be only enough for 3 to 5% of the population.
by Pien Huang
Sep 22, 2020
3 minutes
It's still unknown when a COVID-19 vaccine might be available in the U.S. But when one is first approved, there may only be 10 to 15 million doses available, which may be enough to cover around 3 to 5% of the U.S. population. That's according to estimates from Operation Warp Speed, the government's vaccine project, published in a draft framework from the National Academy of Sciences.
There are many who would benefit from the
You’re reading a preview, subscribe to read more.
Start your free 30 days